Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2016	Dec. 31, 2015
Cash Flows from Operating Activities
Net loss	$ (123,762)	$ (426,634)
Adjustments to reconcile net loss to net cash Used in operating activities:
Depreciation and amortization	32,371	76,579
Amortization of discount	12,884	12,881
Stock based compensation	207,815	390,000
Changes in operating assets and liabilities
Accounts receivable and prepaid expenses	6,324	(30,033)
Employee advances		12,292
Accounts payable and accrued expenses	37,122	(58,056)
Payable to related parties	(26,000)	(15,900)
Cash (Used in) Operating Activities	146,754	(38,871)
Cash Flows From Investing Activities
Purchase of intellectual property		(16,116)
Cash (Used in) Investing Activities		(16,116)
Cash Flows from Financing Activities
Proceeds from note receivable, related party, and accrued interest		41,719
Payments on note payable		(10,867)
Proceeds from notes payable, related party	25,000	25,000
Principal payments on notes payable, related parties	(25,000)
Principal payments on notes payable	(147,569)
Cash (Used) in Provided by Financing Activities	(147,569)	55,852
Net Increase (Decrease) in Cash and Cash Equivalents	(815)	865
Cash and cash equivalents at Beginning of Period	5,601	4,736
Cash and cash equivalents at End of Period	4,786	5,601
Supplemental Disclosure of Cash Flow Information
Cash Paid for Interest	24,977	44,294
Supplemental Schedule of Non-Cash Activities
Note receivable and accrued interest in connection with IP acquisition		41,179
Note Payable in connection with license and IP acquisition	$ 100,000	$ 58,416